
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $131.2M | -- | -- | $0.36 | -- |
07/24/2025 | Q2 | $128M | -- | -- | $0.35 | -- |
04/24/2025 | Q1 | $125M | $126.7M | $0.36 | $0.33 | $0.03 |
01/22/2025 | Q4 | $126.7M | $107.3M | $0.36 | $0.34 | $0.02 |
10/23/2024 | Q3 | $126.9M | $117.3M | $0.37 | $0.35 | $0.02 |
07/24/2024 | Q2 | $127M | $125.1M | $0.36 | $0.35 | $0.01 |
04/24/2024 | Q1 | $126.9M | $126.6M | $0.35 | $0.35 | -$0.00 |
01/24/2024 | Q4 | $132.4M | $139.4M | $0.35 | $0.39 | -$0.04 |
10/25/2023 | Q3 | $134.8M | $137.3M | $0.42 | $0.40 | $0.02 |
07/26/2023 | Q2 | $132M | $132M | $0.40 | $0.39 | $0.01 |
04/26/2023 | Q1 | -- | $138.6M | $0.42 | -- | -- |
01/25/2023 | Q4 | -- | $150.6M | $0.47 | -- | -- |
10/19/2022 | Q3 | -- | $144.7M | $0.46 | -- | -- |
07/20/2022 | Q2 | -- | $133.7M | $0.42 | -- | -- |
04/20/2022 | Q1 | -- | $123.7M | $0.31 | -- | -- |
01/26/2022 | Q4 | -- | $115.4M | $0.35 | -- | -- |
10/21/2021 | Q3 | -- | $113.5M | $0.37 | -- | -- |
07/21/2021 | Q2 | -- | $115.9M | $0.38 | -- | -- |
04/21/2021 | Q1 | -- | $116.9M | $0.47 | -- | -- |
01/28/2021 | Q4 | -- | $119.6M | $0.37 | -- | -- |
10/21/2020 | Q3 | -- | $114.6M | $0.35 | -- | -- |
07/22/2020 | Q2 | -- | $116.7M | $0.31 | -- | -- |
04/22/2020 | Q1 | -- | $113.7M | $0.27 | -- | -- |
01/22/2020 | Q4 | -- | $119.4M | $0.37 | -- | -- |
10/23/2019 | Q3 | -- | $120.1M | $0.36 | -- | -- |
07/24/2019 | Q2 | -- | $123.6M | $0.39 | -- | -- |
04/24/2019 | Q1 | -- | $121M | $0.37 | -- | -- |
01/23/2019 | Q4 | -- | $123.8M | $0.31 | -- | -- |
10/24/2018 | Q3 | -- | $102.9M | $0.30 | -- | -- |
07/18/2018 | Q2 | -- | $82.4M | $0.32 | -- | -- |
04/18/2018 | Q1 | -- | $83.2M | $0.32 | -- | -- |
01/24/2018 | Q4 | -- | $80.4M | $0.16 | -- | -- |
10/18/2017 | Q3 | -- | $81.8M | $0.27 | -- | -- |
07/19/2017 | Q2 | -- | $81.3M | $0.26 | -- | -- |
04/25/2017 | Q1 | -- | $74M | $0.26 | -- | -- |
01/19/2017 | Q4 | -- | $73.9M | $0.25 | -- | -- |
10/19/2016 | Q3 | -- | $72.3M | $0.23 | -- | -- |
07/20/2016 | Q2 | -- | $75.2M | $0.23 | -- | -- |
04/20/2016 | Q1 | -- | $70.8M | $0.22 | -- | -- |
01/21/2016 | Q4 | -- | $72M | $0.27 | -- | -- |
10/22/2015 | Q3 | -- | $74.3M | $0.26 | -- | -- |
CVB Financial reported $126.7M worth of top line sales in its most recent quarter.
CVB Financial announced earnings per share of $0.36 which represents a beat of analyst forecast a $0.33 per share.
CVB Financial reported -- that represents -- per share over the last quarter.
CVB Financial's earnings are forecast to grow from $1.44 per share to $1.43 per share next year representing an increase of --.
CVB Financial's next earnings date is July 24, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.